1. CURRENT MANAGEMENT OF HYPERTENSIONDR.ANKIT JAIN DR.G.KARTHIKEYAN 2. EPIDEMIOLOGY Worldwide prevalence is around 20% , and approximately7.1 million deaths per year…
1. The brachial artery and its relationship with carotid atherosclerosisA xandru A le ndrito iuEmergency Military HospitalCraiova-Romania 2. Theoretical background • Dysfunction…
1. REGISTER BY 6TH JULY AND RECEIVE £300 DISCOUNTREGISTER BY 28TH SEPTEMBER AND RECEIVE £100 DISCOUNT SMi present their... Diabetes, Cardiovascular & Renal Complications…
Slide 1 Dr Manish Ruhela HYPERTENSION IN INDIA Introduction Hypertension is the most common, important preventable condition seen in primary care and leads to Myocardial…
Treatment effects of sleep apnoea: where are we now? B. Buyse* and the participants of working group 2# ABSTRACT: The present article summarises some of the topics of discussion…
1. Is it Possible to Demonstrate a Reduction in Cardiovascular Risk with Drugs for Type 2 Diabetes? 17 September 2013 2. • ICON plc is a global provider of outsourced development…
Slide 1CCR2 variant and cardiovascular outcome in a general population-based cohort Mike Zuurman, PhD Internal Medicine/Nephrology UMCG, Groningen The Netherlands Breedtestrategie…
Slide 1 Both Amiloride and Nebivolol Have a More Favourable Effect on Glucose Tolerance Than Hydrochlorothiazide in the Treatment of Essential Hypertension Stears AJ, Woods…
The role of lercanidipine in the treatment of hypertension: Blood pressure control and beyond Claudio Borghi Department of Internal Medicine, Aging and Kidney Diseases University…